Search for: "Generic Pharmaceutical Association" Results 101 - 120 of 3,010
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Sep 2023, 4:00 am by Jim Sedor
Louis Milione retired from the DEA a second time this summer amid reporting on potential conflicts caused by his prior consulting for the pharmaceutical industry. [read post]
19 Sep 2023, 6:30 am by Michelle Kendler-Kretsch
According to corporate records and a report from South Sudan’s auditor general, a company half-owned by a 9-month-old baby received a letter of credit — a bank’s guarantee that it will provide loaned funds for a purchase or other financial transaction — to import pharmaceutical products into South Sudan. [read post]
18 Sep 2023, 9:05 pm by Cookson Beecher
The company’s thinking is that if you want to make a dent in animal husbandry and the environment by the next generation, the product requires mass adoption. [read post]
17 Sep 2023, 9:06 pm by Patent Docs
This year's co-chairs are Laura DeMoor, IP Associate General Counsel, Baxter Healthcare Corp.; Andrea D. [read post]
14 Sep 2023, 4:00 am by AALL Spectrum
The SALI tags enable firms to generate those types of analytic insights. [read post]
12 Sep 2023, 9:42 am by Mark Ashton
” The problems associated with termination are mostly self-evident. [read post]
11 Sep 2023, 12:44 am by Giannis Psarakis (Psarakis & Kefalas)
Moreover, once established, reputation for innovation also generates ‘innovation credit,’ which in turn mitigates the risks associated with launching innovative products or services—risks particularly tied to the inherent uncertainties of consumer adoption. [read post]
“A METHOD FOR THE TREATMENT OF ACUTE OR CHRONIC OTITIS IN PETS, notably dogs and cats, characterized by comprising the application of an effective amount of the pharmaceutical association defined in any one of claims 1 to 10”. [read post]
While the Act targets drug manufacturers, with a focus on prescription drugs, it applies generally to “pharmaceutical manufacturers” that employ “pharmaceutical representatives. [read post]
Mulready The Tenth Circuit appeals court in Pharmaceutical Care Management Association (PCMA) v. [read post]
15 Aug 2023, 6:37 am by Don Asher
  For more, see What is the Employer’s General Duty Clause? [read post]
11 Aug 2023, 12:01 am by Kluwer IP Reporter
To start off, could you tell a little about IP in general in Trinidad and Tobago? [read post]
8 Aug 2023, 6:20 pm by Kurt R. Karst
  There were tables in each guidance that appear to be consistent where they overlap, but also include different nitrosamines/NDSRIs (FDA guidances are not generally binding law, but, rather, express FDA policy.) [read post]
2 Aug 2023, 2:14 am by Kate O’Sullivan (Bristows)
First Instance decision In 2020, Teva and Sandoz issued proceedings seeking to revoke Astellas’ European Patent (UK) 1 559 427 B1 (the “Patent“) and associated SPC. [read post]
25 Jul 2023, 1:43 am by Matthieu Dhenne (Dhenne Avocats)
EP’415 claims apixaban (claims 1 and 2), the pharmaceutical composition comprising it (claims 3 and 4), the compound and the pharmaceutical composition for use in therapy, in particular to treat thromboembolic disorders (claims 5 to 22), optionally in association with a second therapeutic agent to treat thrombolytic disorders (claims 23 to 29). [read post]
24 Jul 2023, 3:58 am by Fred Rocafort
Everything from luxury goods to electronics and pharmaceuticals are subject to knock-offs. [read post]
17 Jul 2023, 2:02 am by Seth High, Splainers
However, this case study also highlights the risks associated with pre-packaged training, legacy programs, and AI-generated content, which can communicate that your organization is self-serving, uninspired and impersonal. [read post]